Efficacy and Safety of Sotatercept in PH-HFpEF: Results From the Phase 2 CADENCE Trial - report from ACC 2026 episode artwork

EPISODE · Apr 22, 2026 · 4 MIN

Efficacy and Safety of Sotatercept in PH-HFpEF: Results From the Phase 2 CADENCE Trial - report from ACC 2026

from Medical Digest & Congress Report · host Medical Congress News

Professor Mardi Gomberg-Maitland presents the results from the Phase 2 CADENCE trial, investigating the efficacy and safety of Sotatercept in patients with combined post- and pre-capillary pulmonary hypertension associated with heart failure with preserved ejection fraction (HFpEF).Video: https://medicaldigest.org/scientific-contents/interview:efficacy-and-safety-sotatercept-ph-hfpef-results-phase-2-cadence-trial

Episode metadata supplied by the publisher feed · Published Apr 22, 2026

Embed this episode

Ready to play

Efficacy and Safety of Sotatercept in PH-HFpEF: Results From the Phase 2 CADENCE Trial - report from ACC 2026

0:00 4:25

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of Medical Digest & Congress Report?

This episode is 4 minutes long.

When was this Medical Digest & Congress Report episode published?

This episode was published on April 22, 2026.

Can I download this Medical Digest & Congress Report episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!